From Continence to Incontinence: Challenges and Advances in Care

Urinary incontinence (UI), defined as involuntary leakage of urine, is a common condition in women, particularly after 50 years of age. Despite its recognition as a disease by the International Classification of Diseases, UI remains underreported due to stigma and misconceptions, with a significant impact on quality of life, mental health, and social functioning. This review outlines the classification of UI (stress, urge, mixed, overflow, functional), underlying pathophysiology, and contributory factors such as ageing, trauma, surgery, and menopause. Evaluation includes detailed history, physical examination, urological tests, and urodynamic studies to differentiate causes and guide management. Management strategies range from lifestyle modification, pelvic floor muscle therapy, bladder training, and medical interventions (antimuscarinics, β3 adrenergic agonists, vaginal oestrogens) to surgical procedures including mid-urethral slings, urethropexy, periurethral injectables, and artificial sphincters. Emerging therapies such as neuromodulation, onabotulinumtoxin A injections, and electromagnetic devices (Emsella chairs) show promise. UI is strongly associated with depression, sexual dysfunction, poor sleep, and reduced productivity. UI is a multifactorial condition requiring patient-centred, multidisciplinary care. Advances in bladder physiology research, genetic studies, and novel therapies targeting bladder microbiota highlight future directions. Early detection, prevention, and improved patient-reported outcomes remain central to enhancing quality of life in affected women.